- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Kesimpta promo webpage implied unrestricted SMC approval (restriction not in immediate view). A UK HCP banner ad omitted…
Anonymous complaint alleged a Phase 2/3 sarcoma trial flyer in conference bags was pre-licence promotion and inappropriately distributed.…
Anonymous ex-employee alleged Moderna misused preprint vaccine effectiveness data, cherry-picked graphs and sought UK contract advantage via JCVI…
A medical publisher’s “Sponsored” Facebook ad linked to a Lilly-funded breast cancer article. The Panel found disguised promotion,…
A pharmacist challenged claims that Versatis was comparable to pregabalin (and possibly gabapentin) and had fewer side-effects/interactions. The…
GSK and Roche withdrew Bonviva ‘Building Bones’ materials after an undertaking, but Pulse republished the old ad. Panel…
Actiq ad and leavepiece implied breakthrough cancer pain control could be switched “on” and “off” like an appliance.…
Anonymous ex-employee alleged UK doctors were invited to a “lavish” Berlin meeting based on prescribing and that hospitality/entertainment…
Shire challenged Norgine’s ‘NICE recommends MOVICOL Paediatric Plain FIRST-LINE’ ad/leavepiece as unauthorised, unreferenced and implying off-label paediatric use.…
PMCPA case AUTH/3119/11/18 (Director v Pfizer) about clinical trial disclosure. The matter was ruled outwith the scope of…
One real case. One key lesson. Every week — free.